Tuesday, 26 October 2021


Terumo acquires all assets of Health Outcomes Sciences

24 February 2021 | News

The acquisition is expected to close in February 2021

Source credit: Shutterstock

Source credit: Shutterstock

Japan based Terumo Corporation, a global leader in medical technology, has signed a definitive agreement to acquire all assets of US based Health Outcomes Sciences, Inc (HOS). HOS specialises in predictive analytics and clinical decision support that enable healthcare organisations to deliver personalised, predictive insights at the point of care, resulting in significant and measurable improvements in clinical, patient and financial outcomes.

The acquisition is expected to close in February 2021. Following the close, the ePRISM platform will be integrated into Terumo Business Edge, a business unit of Terumo Medical Corporation that provides healthcare systems with solutions designed to reduce care variation, improve quality metrics, minimise cost and maximise revenue.

"The acquisition of Health Outcomes Sciences and the ePRISM® platform expands Terumo's presence in the digital healthcare arena and represents a compelling growth opportunity for our company. It further allows Terumo to deliver innovative digital solutions, providing healthcare systems with critical data needed to lower the cost of healthcare delivery while substantially improving patient outcomes," said Toshi Osada, President Terumo Corporation's Cardiac and Vascular Company.

Rather than relying on broader, generalised population data, ePRISM delivers each patient's unique risks to physicians prior to treatment. By calculating and assembling a patient's actual procedural risk, that includes their unique disease severity, co-morbidities and demographics, ePRISM provides valuable data to enable providers to tailor the intensity of treatment to patients' unique risks. The use of validated predictive models in routine care has the capacity to improve the consistency, outcomes and cost-effectiveness of care across various cardiac procedures and care pathways.

"When combined with Terumo's 100-year history and commitment to transforming global healthcare, our ePRISM technology will enable healthcare providers to deliver uniquely focused patient care; improving patient satisfaction, decreasing variability, optimising outcomes and minimising costs. This acquisition provides Terumo with a digital solutions platform that can be scaled globally across multiple healthcare segments," said John Spertus, MD, MPH, FACC, FAHA and Founder of Health Outcomes Sciences.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account